U.s. Army Medical Research And Development Command

This study tested an experimental HIV vaccine in 65 healthy, HIV-negative adults to find the safest and most effective dose of an immune-boosting ingredient (adjuvant). Participants received three shots over two months and were monitored for side effects and immune responses for …

This study tested a new rapid test called CL Detect™ for diagnosing cutaneous leishmaniasis, a skin infection caused by a parasite. Researchers compared the test's accuracy to the standard method of looking at skin samples under a microscope. The study involved 150 adults in the …

This study tested an experimental vaccine (G03-52-01) in 622 healthy adults to see if it is safe and can produce antibodies that neutralize botulinum toxin, the cause of botulism. Participants received either the vaccine or a placebo, and researchers measured side effects and imm…